UTIs

FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women
BioSpace
Thu, 04/25/24 - 11:37 am
UTILITY Therapeutics
FDA
pivmecillinam
Pivya
UTIs
Oral vaccine for UTI is potential alternative to antibiotics, finds 9-year study
Medical Xpress
Mon, 04/8/24 - 12:00 pm
Immunotek
UTIs
vaccines
MV140
GSK's gepotidacin shows potential in urinary tract infections
Marketscreener
Mon, 04/17/23 - 11:39 am
GSK
antibiotics
UTIs
gepotidacin
GSK preps filing for novel antibiotic for urinary tract infections
Pharmaphorum
Mon, 11/7/22 - 10:58 am
GSK
antibiotics
UTIs
gepotidacin
Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States
BioSpace
Wed, 11/2/22 - 10:16 am
Illumina
diagnostics
UTIs
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
Endpoints
Fri, 07/15/22 - 10:55 am
antibiotics
antibiotic resistance
UTIs
Big Pharma
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Fierce Biotech
Thu, 03/10/22 - 10:29 am
VenatoRx
antibiotics
clinical trials
FDA
UTIs
Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs
Biopharma Reporter
Thu, 02/25/21 - 10:36 am
bacteriophage
phage
CRISPR
Locus Biosciences
precision medicine
UTIs
clinical trials
Iterum nabs speedy FDA antibiotic review, but follows in the footsteps of bankrupt biotechs
Fierce Biotech
Tue, 01/26/21 - 11:16 am
Iterum
sulopenem
priority review
FDA
UTIs
antibiotics
Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Endpoints
Tue, 11/10/20 - 11:02 am
Locus Biosciences
CARB-X
CRISPR
rUTIs
UTIs
bacteriophage
EIP Pharma
Vertex Pharmaceuticals
dementia
clinical trials
BARDA and Locus in tie-up to tackle UTIs with phages
Biopharma Reporter
Mon, 10/12/20 - 10:30 am
Locus Biosciences
BARDA
LBP-EC01
CRISPR
bacteriophage
UTIs
Allecra's Exblifep Effective in Hospital-Based Urinary Tract Infections
BioSpace
Tue, 02/25/20 - 10:23 am
Allecra
complicated urinary tract infections
UTIs
Exblifep
clinical trials
After positive panel vote, Shionogi antibiotic scores US approval
Endpoints
Fri, 11/15/19 - 10:50 am
Shionogi
antibiotics
FDA
cUTI
UTIs
Fetroja
Paratek's top antibiotic fails to clear a key competitive hurdle in head-to-head studies
Endpoints
Fri, 11/1/19 - 10:28 am
Nuzyra
UTIs
Paratek
Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote
Endpoints
Thu, 10/17/19 - 10:28 am
Shionogi
FDA
advisory panels
antibiotics
cefiderocol
UTIs
In-house FDA review flags a suspicious imbalance in deaths as Shionogi hunts an OK for antibiotic
Endpoints
Mon, 10/14/19 - 10:26 am
Shionogi
FDA
advisory panels
antibiotics
UTIs
cefiderocol
VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs
Pharmaceutical Business Review
Fri, 08/30/19 - 01:05 pm
VenatoRx
clinical trials
UTIs
complicated urinary tract infections
cefepime
VNRX-5133
Merck's combination antibiotic scores FDA approval for urinary tract and abdominal infections
Endpoints
Wed, 07/17/19 - 09:46 am
Merck
FDA
UTIs
intra-abdominal infections
Recarbrio
Nearing phase 3, resTORbio posts new data on infection drug
Fierce Biotech
Tue, 10/16/18 - 09:46 am
ResTORbio
RTB101
respiratory infections
UTIs
It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri
Fierce Pharma
Wed, 06/27/18 - 10:18 am
Achaogen
FDA
Zemdri
antibiotics
UTIs

Pages